Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
Maliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112963-112963
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence
Yi Qin, Milad Ashrafizadeh, Vera Mongiardini, et al.
Cancer Letters (2023) Vol. 570, pp. 216307-216307
Closed Access | Times Cited: 153
Tumor hypoxia: From basic knowledge to therapeutic implications
Chengheng Liao, Xijuan Liu, Cheng Zhang, et al.
Seminars in Cancer Biology (2023) Vol. 88, pp. 172-186
Open Access | Times Cited: 88
Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114204-114204
Open Access | Times Cited: 74
Long non-coding RNAs in lung cancer: Unraveling the molecular modulators of MAPK signaling
Md Sadique Hussain, Obaid Afzal, Gaurav Gupta, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154738-154738
Closed Access | Times Cited: 68
lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways
Raed Obaid Saleh, Mushtak T.S. Al-Ouqaili, Eyhab Ali, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 19
Exosomes in Cancer: Diagnostic and Therapeutic Applications
Quratulain Maqsood, Aleena Sumrin, Yasar Saleem, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access | Times Cited: 17
Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis
Sajad Najafi, Seyyed Hossein Khatami, Marjan Khorsand, et al.
Experimental Cell Research (2022) Vol. 418, Iss. 2, pp. 113294-113294
Closed Access | Times Cited: 61
LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside
Qin Hu, Huiyun Ma, Hongyu Chen, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 48
Liquid biopsy on the horizon in immunotherapy of non-small cell lung cancer: current status, challenges, and perspectives
Ying Yang, Hongyang Liu, Youming Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 36
Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma
Gao Shan, Minchao Kang, Wang Jizhao, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 229, pp. 115346-115346
Closed Access | Times Cited: 31
From carcinogenesis to therapeutic avenues: lncRNAs and mTOR crosstalk in lung cancer
Md Sadique Hussain, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155015-155015
Closed Access | Times Cited: 25
Expanding the horizon of EV-RNAs: LncRNAs in EVs as biomarkers for disease pathways
Michail Spanos, Priyanka Gokulnath, Emeli Chatterjee, et al.
Extracellular Vesicle (2023) Vol. 2, pp. 100025-100025
Open Access | Times Cited: 24
The potential role of circular RNAs -regulated PI3K signaling in non-small cell lung cancer: Molecular insights and clinical perspective
Samaneh Kahkesh, Seyedeh Mahdieh Khoshnazar, Yasaman Gholinezhad, et al.
Pathology - Research and Practice (2024) Vol. 257, pp. 155316-155316
Closed Access | Times Cited: 12
Functional Relevance of Extracellular Vesicle-Derived Long Non-Coding and Circular RNAs in Cancer Angiogenesis
José A. Peña-Flores, Daniela Muela‐Campos, Rebeca Guzmán-Medrano, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 1, pp. 12-12
Open Access | Times Cited: 9
Exploring the therapeutic potential of quercetin in cancer treatment: Targeting long non-coding RNAs
Farhad Sheikhnia, Ahmad Fazilat, Vahid Rashidi, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155374-155374
Closed Access | Times Cited: 8
Exploring Cellular Plasticity and Resistance Mechanisms in Lung Cancer: Innovations and Emerging Therapies
Caiyu Jiang, Shenglong Xie, Kegang Jia, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101179-101179
Open Access | Times Cited: 1
LncRNA TCL6 regulates miR-876–5p/MYL2 axis to suppress breast cancer progression
Yaobang Liu, Haipeng Li, Dahai Chai, et al.
Translational Oncology (2025) Vol. 53, pp. 102210-102210
Closed Access | Times Cited: 1
Exosomes as Therapeutic and Diagnostic Tools: Advances, Challenges, and Future Directions
Tejas C. Jangam, Sharav Desai, Vipul P. Patel, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access | Times Cited: 1
Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential
Wen-Qin Zhang, Yuanliang Yan, Jinwu Peng, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 286-286
Open Access | Times Cited: 31
Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts
Naushad Ahmad Khan, Mohammad Asim, Kabir H. Biswas, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 21
Towards dual function of autophagy in breast cancer: A potent regulator of tumor progression and therapy response
Mehrdad Hashemi, Mahshid Deldar Abad Paskeh, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114546-114546
Open Access | Times Cited: 20
Exosomes‐mediated crosstalk between glioma and immune cells in the tumor microenvironment
Xu Guo, Rui Sui, Haozhe Piao
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2074-2085
Open Access | Times Cited: 17
Long Non-Coding RNAs as Emerging Targets in Lung Cancer
Jovanka Gencel‐Augusto, Wei Wu, Trever G. Bivona
Cancers (2023) Vol. 15, Iss. 12, pp. 3135-3135
Open Access | Times Cited: 15
The cross-talk between LncRNAs and JAK-STAT signaling pathway in cancer
Ahmed Hjazi, Rasha Fadhel Obaid, Sally Saad Ali, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154657-154657
Closed Access | Times Cited: 14
The pharmacological and biological importance of EZH2 signaling in lung cancer
Maliheh Entezari, Afshin Taheriazam, Mahshid Deldar Abad Paskeh, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114313-114313
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top